Peter Slover
Förmögenhet: 51 768 $ per 2026-07-31
Förmögenhet: 51 768 $ per 2026-07-31
Mr. Peter T.
Slover, CPA, is a Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. Mr. Slover was previously employed as a Chief Financial & Accounting Officer by Sophiris Bio, Inc., a Vice President-Finance & Operations by Anadys Pharmaceuticals, Inc., and an Auditor by KPMG LLP.
He received his undergraduate degree from Shippensburg University of Pennsylvania.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-17 | 3 342 ( 0,01 % ) | 51 768 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Finansdirektör/CFO | 2020-09-01 |
| Företag | Position | Slut |
|---|---|---|
| SOPHIRIS BIO | Finansdirektör/CFO | 2020-05-01 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Finansdirektör/CFO | - |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Företagsledare/Principal | 2004-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån